Noticias de AGEN_US

Noticias del mercado

Últimas noticias sobre AGEN_US — 154 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AGEN_US ✕ 154 resultados
28/04/2026 AGEN_US — BioSpace
AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer
28/04/2026 AGEN_US — Stock Titan
Director Susan B. Hirsch receives 105,000 Agenus (NASDAQ: AGEN) stock options
28/04/2026 AGEN_US — Stock Titan
Equity grants: Agenus (AGEN) awards 305,000 stock options to director-officer Buell
28/04/2026 AGEN_US — Stock Titan
Agenus (NASDAQ: AGEN) accounting chief awarded stock options in lieu of cash bonus
28/04/2026 AGEN_US — Stock Titan
Stock options granted to Agenus (AGEN) director and officer Armen Garo
28/04/2026 AGEN_US — Stock Titan
Agenus (AGEN) director Brian Corvese granted 210,000 stock options
28/04/2026 AGEN_US — Stock Titan
Director Timothy Wright receives 105K AGEN (NASDAQ: AGEN) stock options grant
27/04/2026 AGEN_US — The National Law Review
Agenus to Host First 2026 Stakeholder Webcast
24/04/2026 AGEN_US — newswire.co.kr
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs

Agenus Inc. (Nasdaq: AGEN), líder en innovación en inmunooncología, y BAP Pharma, una empresa global de acceso a medicamentos y suministro de ensayos clínicos, hoy

23/04/2026 AGEN_US — press.todayan.com
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
23/04/2026 AGEN_US — Yahoo Finance
Here's Why Agenus (AGEN) is a Strong Momentum Stock
23/04/2026 AGEN_US — MSN
Agenus Q4 2025 earnings preview
23/04/2026 AGEN_US — MSN ES ← EN
Vista previa de las ganancias del cuarto trimestre de 2025 de Agenus

Agenus Q4 2025 earnings preview

22/04/2026 AGEN_US — tayninh.gov.vn ES ← EN
La pérdida de AGEN (Agenus Inc.) en el cuarto trimestre de 2025 fue mucho menor de lo esperado, las acciones subieron un 3,23 por ciento en la sesión de hoy.

AGEN (Agenus Inc.) Q4 2025 loss far narrower than expected, shares rise 3.23 percent in today’s session.

22/04/2026 AGEN_US — Xã Thanh Hà
AGEN (Agenus Inc.) Q4 2025 loss far narrower than expected, shares rise 3.23 percent in today’s session.
22/04/2026 AGEN_US — news.google.com
AGEN (Agenus Inc.) Q4 2025 loss far narrower than expected, shares rise 3.23 percent in today’s session. - Community Trade Ideas
22/04/2026 AGEN_US — Investing.com
Agenus presents four abstracts on cancer therapies at ASCO By Investing.com
22/04/2026 AGEN_US — BioSpace
Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026
21/04/2026 AGEN_US — Investing.com
Agenus presents four abstracts on cancer therapies at ASCO By Investing.com
21/04/2026 AGEN_US — The Joplin Globe ES ← PT-PT
Agenus nombra a BAP Pharma como socio global exclusivo para BOT+BAL

Agenus designa a BAP Pharma como socio global exclusivo para BOT+BAL

Página 3 de 8

keyboard_arrow_up